Filing Details

Accession Number:
0000950170-24-131499
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-27 16:16:41
Reporting Period:
2024-11-27
Accepted Time:
2024-11-27 16:16:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1880438 An2 Therapeutics Inc. ANTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1331852 S Joseph Zakrzewski C/O An2 Therapeutics, Inc.
1800 El Camino Real, Suite D
Menlo Park CA 94027
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-27 2,000 $1.40 125,199 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 405,880 Indirect See Footnote
Footnotes
  1. These shares are held by Z3 Trust, for which the Reporting Person is a trustee.